# Myriad Genetics Inc: filings

MYGN · Nasdaq · CIK 899923 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mygn.md) · [Financials](/companies/mygn/financials.md) · [Filings](/companies/mygn/filings.md) · [Insiders](/companies/mygn/insiders.md)

## Reports and events: 281 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 887, 8-K 187, SC 13G/A 92, 10-Q 53, 3 43, SC 13G 31, DEFA14A 21, 144 19, S-8 19, DEF 14A 18, 10-K 17, SCHEDULE 13G/A 15, 5 11, ARS 11, UPLOAD 7, 8-K/A 5, CORRESP 4, SCHEDULE 13G 4, 4/A 3, 3/A 2, 424B5 2, CT ORDER 2, DEFR14A 2, S-3ASR 2, 10-K/A 1, 10-KT 1, 424B3 1, D 1, D/A 1, EFFECT 1, NT 10-K 1, PRE 14A 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 08:36 ET | [8-K](/filings/0000899923-26-000094.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-26-000094 |
| 2026-10-09 | 16:16 ET | [8-K](/filings/0000899923-26-000084.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000899923-26-000084 |
| 2026-09-16 | 08:00 ET | [8-K](/filings/0000899923-26-000079.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-26-000079 |
| 2026-07-31 | 08:01 ET | [10-Q](/filings/0000899923-26-000072.md) | Quarterly report, period 2026-06-30 | 0000899923-26-000072 |
| 2026-07-30 | 16:07 ET | [8-K](/filings/0000899923-26-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-26-000070 |
| 2026-06-23 | 08:32 ET | [8-K](/filings/0000899923-26-000062.md) | 5.02 Departure or appointment of officers or directors | 0000899923-26-000062 |
| 2026-06-04 | 16:08 ET | [8-K](/filings/0000899923-26-000059.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000899923-26-000059 |
| 2026-05-06 | 06:05 ET | [10-Q](/filings/0000899923-26-000038.md) | Quarterly report, period 2026-03-31 | 0000899923-26-000038 |
| 2026-05-05 | 16:07 ET | [8-K](/filings/0000899923-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-26-000036 |
| 2026-04-14 | 17:01 ET | [DEF 14A](/filings/0000899923-26-000031.md) | Proxy statement, period 2025-12-31 | 0000899923-26-000031 |
| 2026-02-24 | 16:01 ET | [10-K](/filings/0000899923-26-000018.md) | Annual report, period 2025-12-31 | 0000899923-26-000018 |
| 2026-02-23 | 16:07 ET | [8-K](/filings/0000899923-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-26-000012 |
| 2026-01-12 | 08:31 ET | [8-K](/filings/0000899923-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-26-000003 |
| 2025-11-04 | 06:18 ET | [10-Q](/filings/0000899923-25-000112.md) | Quarterly report, period 2025-09-30 | 0000899923-25-000112 |
| 2025-11-04 | 20:42 ET | [8-K/A](/filings/0000899923-25-000109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000109 |
| 2025-11-03 | 16:07 ET | [8-K](/filings/0000899923-25-000103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000103 |
| 2025-10-07 | 16:02 ET | [8-K](/filings/0000899923-25-000096.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000899923-25-000096 |
| 2025-10-03 | 16:27 ET | [8-K](/filings/0000899923-25-000091.md) | 5.02 Departure or appointment of officers or directors | 0000899923-25-000091 |
| 2025-08-18 | 08:31 ET | [8-K](/filings/0000899923-25-000089.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000899923-25-000089 |
| 2025-08-06 | 06:09 ET | [10-Q](/filings/0000899923-25-000086.md) | Quarterly report, period 2025-06-30 | 0000899923-25-000086 |
| 2025-08-05 | 16:06 ET | [8-K](/filings/0000899923-25-000084.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000084 |
| 2025-07-31 | 09:27 ET | [8-K](/filings/0000899923-25-000072.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000899923-25-000072 |
| 2025-06-05 | 16:32 ET | [8-K](/filings/0000899923-25-000066.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000899923-25-000066 |
| 2025-05-07 | 20:48 ET | [10-Q](/filings/0000899923-25-000048.md) | Quarterly report, period 2025-03-31 | 0000899923-25-000048 |
| 2025-05-06 | 16:08 ET | [8-K](/filings/0000899923-25-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000045 |
| 2025-04-09 | 16:06 ET | [DEF 14A](/filings/0000899923-25-000028.md) | Proxy statement, period 2024-12-31 | 0000899923-25-000028 |
| 2025-02-28 | 16:05 ET | [10-K](/filings/0000899923-25-000019.md) | Annual report, period 2024-12-31 | 0000899923-25-000019 |
| 2025-02-24 | 16:26 ET | [8-K](/filings/0000899923-25-000010.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-25-000010 |
| 2025-01-15 | 08:39 ET | [8-K](/filings/0000899923-25-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-25-000002 |
| 2024-12-10 | 16:08 ET | [8-K](/filings/0000899923-24-000065.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000899923-24-000065 |
| 2024-11-26 | 16:42 ET | [8-K](/filings/0000899923-24-000060.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-24-000060 |
| 2024-11-08 | 08:18 ET | [10-Q](/filings/0000899923-24-000057.md) | Quarterly report, period 2024-09-30 | 0000899923-24-000057 |
| 2024-11-07 | 16:11 ET | [8-K](/filings/0000899923-24-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000054 |
| 2024-10-09 | 06:11 ET | [8-K](/filings/0000899923-24-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000048 |
| 2024-09-04 | 20:43 ET | [8-K](/filings/0000899923-24-000045.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-24-000045 |
| 2024-08-07 | 08:22 ET | [10-Q](/filings/0000899923-24-000041.md) | Quarterly report, period 2024-06-30 | 0000899923-24-000041 |
| 2024-08-06 | 16:09 ET | [8-K](/filings/0000899923-24-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000036 |
| 2024-06-06 | 16:06 ET | [8-K](/filings/0000899923-24-000028.md) | 5.07 Shareholder vote results | 0000899923-24-000028 |
| 2024-06-03 | 16:06 ET | [8-K](/filings/0000899923-24-000027.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-24-000027 |
| 2024-05-08 | 08:14 ET | [10-Q](/filings/0000899923-24-000026.md) | Quarterly report, period 2024-03-31 | 0000899923-24-000026 |
| 2024-05-07 | 16:05 ET | [8-K](/filings/0000899923-24-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000025 |
| 2024-04-17 | 16:31 ET | [DEF 14A](/filings/0000899923-24-000022.md) | Proxy statement, period 2023-12-31 | 0000899923-24-000022 |
| 2024-02-28 | 08:31 ET | [10-K](/filings/0000899923-24-000018.md) | Annual report, period 2023-12-31 | 0000899923-24-000018 |
| 2024-02-27 | 16:05 ET | [8-K](/filings/0000899923-24-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000014 |
| 2024-01-16 | 09:00 ET | [8-K](/filings/0000899923-24-000005.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-24-000005 |
| 2023-12-21 | 08:30 ET | [8-K](/filings/0000899923-23-000117.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000899923-23-000117 |
| 2023-11-13 | 16:31 ET | [8-K](/filings/0000899923-23-000110.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000899923-23-000110 |
| 2023-11-09 | 21:16 ET | [8-K](/filings/0000899923-23-000102.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000899923-23-000102 |
| 2023-11-07 | 08:30 ET | [10-Q](/filings/0000899923-23-000087.md) | Quarterly report, period 2023-09-30 | 0000899923-23-000087 |
| 2023-11-06 | 16:05 ET | [8-K](/filings/0000899923-23-000083.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000899923-23-000083 |

Page 1 of 6. [Older](/companies/mygn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:12 ET. No prices; not investment advice.